Navigate this Section
Recent advances in biomedical and health sciences—from immunotherapy to treat cancer, to the highly effective COVID-19 vaccines—demonstrate the strengths and successes of the U.S. biomedical enterprise. Such advances present an opportunity to revolutionize how to prevent, treat, and even cure a range of diseases including cancer, infectious diseases, Alzheimer’s disease, and many others that together affect a significant number of Americans. The Advanced Research Projects Agency for Health (ARPA-H) will provide a novel pathway to catalyzing transformative health breakthroughs that cannot readily be accomplished through traditional research or commercial activity.
To improve the U.S. government’s capabilities to speed research that can improve the health of all Americans, President Biden is proposing the establishment of ARPA-H. Included in the President’s FY2022 budget as a component of the National Institutes of Health (NIH) with a requested funding level of $6.5 billion available for three years, ARPA-H will be tasked with building high-risk, high-reward capabilities (or platforms) to drive biomedical breakthroughs – ranging from molecular to societal – that would provide transformative solutions for all patients.
For more information on ARPA-H and related planning activities, please click here.
For a list of frequently asked questions please click here .
White House Office of Science and Technology Policy & National Institutes Of Health Listening Sessions for ARPA-H: Summary Report can be found here.